Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Most doses of Novo Nordisk's Ozempic are removed from FDA drug shortage list after supply issues
3 years ago
Manufacturing
Marketing
California takes another step forward in its insulin production with $50M investment
3 years ago
Manufacturing
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
3 years ago
Law
Verastem's new campaign aims to make distinctions in rare type of ovarian cancer
3 years ago
Marketing
Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
3 years ago
FDA+
Pfizer's Bourla and Moderna's Bancel saw compensation bumps in 2022
3 years ago
People
Amgen cites inflation, pressure on drug prices in 450-person layoff
3 years ago
People
FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid
3 years ago
FDA+
Merck's Keytruda plus TIGIT combo proves less effective than chemo in open-label lung cancer study
3 years ago
R&D
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
3 years ago
SEC says Eli Lilly can't avoid requests for more info on diversity efforts, abortion stance
3 years ago
ViiV's newest campaign aims to normalize sex and health discussions to help HIV prevention among Black women
3 years ago
Marketing
AbbVie-sponsored eczema documentary debuts at South by Southwest
3 years ago
Marketing
Dr. Reddy’s divests $33M worth of dermatology brands in India
3 years ago
Deals
Novo Nordisk suspended from leading UK trade group over obesity marketing 'breach'
3 years ago
Marketing
CMS explains how it will negotiate the most expensive drug prices with biopharma beginning in 2026
3 years ago
Law
Bristol Myers meets some diversity goals early, while missing others
3 years ago
Eli Lilly’s alopecia drug Olumiant off to positive start with doctors, Spherix research finds
3 years ago
Marketing
Brookings panel of experts lays out case for onshoring manufacturing
3 years ago
Manufacturing
Updated: Amgen sued in federal court for allegedly hiding $10.7B IRS bill from investors
3 years ago
Law
GSK drives RSV awareness to center court with Magic Johnson
3 years ago
Marketing
Bristol Myers blasts off with SpaceX to study biomanufacturing in space
3 years ago
Manufacturing
Jounce faces hostile takeover bid from minority stakeholder
3 years ago
Deals
Five Pfizer drugs among first 27 now subject to Medicare inflation rebates, HHS says
3 years ago
Law
First page
Previous page
138
139
140
141
142
143
144
Next page
Last page